Lixte Biotechnology share price today

(LIXT)

Lixte Biotechnology share price is $2.09 & ₹178.06 as on 25 Dec 2024, 2.30 'hrs' IST

$2.09

Market is closed - opens 8 PM, 26 Dec 2024

View live Lixte Biotechnology share price in Dollar and Rupees. Guide to invest in Lixte Biotechnology from India. Also see the sentimental analysis on Indian investors investing in Lixte Biotechnology. Get details on the Indian mutual funds that are investing in Lixte Biotechnology. Get Analyst recommendations and forecasts along with all the Lixte Biotechnology's financials.

Lixte Biotechnology share price movements

Today's Low: $1.95
Today's High: $2.10
$2.09
6.79%
Downside
Day's Volatility :7.24%
Upside
0.48%
52 Weeks Low: $1.31
52 Weeks High: $4.40
$2.09
37.32%
Downside
52 Weeks Volatility :70.23%
Upside
52.5%

Lixte Biotechnology Returns

Period	Lixte Biotechnology Holdings Inc	Index (Russel 2000)
3 Months	12.38%	0.0%
6 Months	-11.8%	0.0%
1 Year	-7.92%	0.0%
3 Years	-83.14%	-21.1%

Lixte Biotechnology Key Statistics

in dollars & INR

Previous Close	$2.09
Open	$2.1
Today's High	$2.1
Today's Low	$1.948
Market Capitalization	$4.7M
Today's Volume	$2.7K
52 Week High	$4.4
52 Week Low	$1.31
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-1.73
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-163.33%

How to invest in Lixte Biotechnology from India?

It is very easy for Indian residents to invest directly in Lixte Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lixte Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lixte Biotechnology or LIXT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lixte Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lixte Biotechnology shares which would translate to 0.408 fractional shares of Lixte Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lixte Biotechnology, in just a few clicks!

Returns in Lixte Biotechnology for Indian investors in Rupees

Investment Value

₹1,00,000

Lixte Biotechnology investment value today

Current value as on today

₹94,309

Returns

₹5,691

(-5.69%)

Returns from Lixte Biotechnology Stock

₹7,930 (-7.93%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Lixte Biotechnology

-58%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Lixte Biotechnology on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -58% less investors are searching Lixte Biotechnology in the last 30 days versus the previous period.

Global Institutional Holdings in Lixte Biotechnology

HighTower Advisors, LLC
4.42%
FNY Investment Advisers, LLC
2.24%
Ethos Financial Group LLC
1.10%
Geode Capital Management, LLC
0.76%
Tower Research Capital LLC
0.09%
UBS Group AG
0.02%

Analyst Recommendation on Lixte Biotechnology

Insights on Lixte Biotechnology

Price Movement
In the last 7 days, LIXT stock has moved up by 9.4%
LIXT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 32.6%
LIXT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 108.3%

Lixte Biotechnology Technicals Summary

Sell

Neutral

Buy

Lixte Biotechnology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lixte Biotechnology Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lixte Biotechnology Holdings Inc	1.47%	-11.8%	-7.92%	-83.14%	-94.41%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lixte Biotechnology Holdings Inc	NA	NA	0.0	0.0	-1.63	-0.87	NA	0.22
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lixte Biotechnology Holdings Inc	NA	$4.7M	-94.41%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Lixte Biotechnology

lixte biotechnology holdings, inc. (lixte) is a clinical-stage public (lixt) pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. the current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and dna damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation. the phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general as well as radiation therapy making them potentially useful for the treatment of many, if not all, cancers in combination with existing standard chemotherapy regimens and the evolving targeted cytotoxic therapies of personalized cancer medicine. the lead compound lb-100 is in phase i trial and has the potential to be first-in-class. the deacetylase in

Organization	Lixte Biotechnology
Employees	3
CEO	Mr. Bastiaan van der Baan M.Sc.
Industry	Biotechnology

Management People of Lixte Biotechnology

Name	Title
Mr. Bastiaan van der Baan M.Sc.	President, CEO & Chairman of the Board of Directors
Mr. Robert Neal Weingarten	VP & CFO
Mr. Eric J. Forman J.D.	VP & COO
Mr. Johannes Henricus Matthias Schellens M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in Lixte Biotechnology from India :

What is Lixte Biotechnology share price today?

Lixte Biotechnology share price today stands at $2.09, Open: $2.10 ; Previous Close: $2.09 ; High: $2.10 ; Low: $1.95 ; 52 Week High: $4.40 ; 52 Week Low: $1.31. The stock opens at $2.10, after a previous close of $2.09. The stock reached a daily high of $2.10 and a low of $1.95, with a 52-week high of $4.40 and a 52-week low of $1.31.

Can Indians buy Lixte Biotechnology shares?

Yes, Indians can invest in the Lixte Biotechnology (LIXT) from India.

With INDmoney, you can buy Lixte Biotechnology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lixte Biotechnology at zero transaction cost.

How can I buy Lixte Biotechnology shares from India?

It is very easy to buy Lixte Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lixte Biotechnology be purchased?

Yes, you can buy fractional shares of Lixte Biotechnology with INDmoney app.

What are the documents required to start investing in Lixte Biotechnology stocks?

To start investing in Lixte Biotechnology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.